If you loved the COVID-19 mRNA shots marketed as “vaccines” based on novel, untested technology, developed and injected into millions of arms at “Warp Speed,” you’re going to be amped about what biomedical goodies Google has in store.
And we won’t have to wait long, as they’ll be in clinical trials, according to promises the company made at the World Economic Forum, by as early as 2025.
Related: WATCH: Pfizer CEO Flops Attempting to Defend Vax Liability Shield
Via PYMNTS (emphasis added):
Nobel laureate and Google DeepMind CEO Demis Hassabis said Tuesday (Jan. 21) that he expects to see pharmaceutical drugs designed by artificial intelligence (AI) to be in clinical trials by the end of the year.
During a fireside chat at the World Economic Forum in Davos, Switzerland, Hassabis said these drugs are being developed at Isomorphic Labs, a for-profit venture created by Google parent firm Alphabet in 2021 that was tasked to reinvent the entire drug discovery process based on first principles and led by AI.
To hear DeepMind CEO Demis Hassabis tell it, Google’s for-profit AI drug development program is really, at the end of the day, an exercise in philanthropic humanitarianism, conceived out of deep concern for the welfare of the peasants in its care on its techno-fiefdom:
Over two million, two and a half million, researchers around the world use it. We’ve folded all proteins known to science, all 200 million. Usually it would take five years, average, you know, several years to do that experimentally. So, if you times, the rule of thumb is it takes a PhD student their entire PhD to find the structure of one protein. So 200 million would take a billion years of PhD time. And we’ve just given all that to the world for free… I call it science at digital speed… We’re usd to digital technology disseminating fast around the world. And I think that can start happening with scientific breakthroughs and help with things like medicine and health.
Google DeepMind CEO Demis Hassabis says their AlphaFold AI system has performed a billion years of PhD work and they will have their first drugs in the clinic by the end of the year, with cancer, heart disease and neurodegenerative diseases on the list of targets pic.twitter.com/CUpA6YfxJG
— Tsarathustra (@tsarnick) January 23, 2025
Of course, only the most committed luddite would oppose using technology to enhance the provision of healthcare. Mapping out hundreds of millions of proteins, for instance — the example cited by Hassabis — in a tiny fraction of the time it would take a human to do it is an undeniable boon for science.
Related: Trump USDA Announces $1 Billion Bird Flu Spend, $100 Million for ‘New Generation’ Vaccines
But before we dive headfirst into the Brave New World, perhaps a few questions are worth asking:
- What are the true motivations of Google to develop this technology?
- What applications for this new tech is it not so excited about sharing publicly?
- What kind of regulatory oversight, if any, will there be for these tools?
- How can Google guarantee that this technology won’t be used by malicious state or non-state actors for bioterrorism purposes, or is this a hope-for-the-best situation?
President Trump's speech to a joint session of Congress has radical Democrats in panic mode, and their childish protests won't stop all of the winning.
Help PJ Media continue to tell the truth about the Trump administration's accomplishments as we continue to usher in the Golden Era of America. Join PJ Media VIP and use promo code FIGHT to get 60% off your membership.
